Laurent Debussche

USPTO Granted Patents = 10 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Paris, FR (2003)
91200 Athis Mons, FR (2000 - 2005)
Athis Mons, FR (1999 - 2006)

Company Filing History:

Rhone-poulenc Rorer S.a.

patents

1 out of 1

Rhone-poulenc Biochimie, Et Al.

5. 2 out of 832,843

Other

patents

Years Active: 1999-2006

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7090999 - Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use (2006-08-15),

2. 6852509 - Anti-P53 single-chain antibody fragments and their uses (2005-02-08),

3. 6833382 - Streptogramins and method for preparing same by mutasynthesis (2004-12-21),

4. 6670157 - Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use (2003-12-30),

5. 6656709 - Methods of increasing the production of cobalamins using cob gene expression (2003-12-02),

6. 6352839 - Streptogramins for preparing same by mutasynthesis (2002-03-05),

7. 6171846 - Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use (2001-01-09),

8. 6156545 - Biosynthesis method enabling the preparation of cobalamins (2000-12-05),

9. 6077699 - Polypeptides involved in the biosynthesis of streptogramins, nucleotide (2000-06-20),

10. 5891695 - Polypeptides involved in the biosynthesis of streptogramins, nucleotide (1999-04-06),

Title: The Innovative Contributions of Laurent Debussche

Introduction

Laurent Debussche is a prominent inventor based in Athis Mons, France. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. With a total of 10 patents to his name, Debussche's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, one notable invention is related to polypeptides involved in the biosynthesis of streptogramins. This invention concerns methods for preparing pristinamycin IIA or IIB. Another significant patent focuses on anti-P53 single-chain antibody fragments and their uses. This invention addresses single-chain antibodies directed against the p53 protein, which are capable of being expressed in tumoral cells. These antibodies can restore DNA binding in vitro and transcription activator function in vivo. The invention also includes nucleic acids coding for these molecules, as well as the vectors containing them and their applications.

Career Highlights

Debussche has worked with notable companies in the pharmaceutical industry, including Aventis Pharma S.A. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in therapeutic solutions.

Collaborations

Throughout his career, Laurent Debussche has collaborated with esteemed colleagues such as Denis Thibaut and Francis Blanche. These partnerships have fostered a collaborative environment that has enhanced the quality and impact of his inventions.

Conclusion

Laurent Debussche's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His innovative work continues to influence medical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.